The Business Development Associate (BDA) is a junior-level position supporting industry engagement with UB related to technology development. The BDA provides "sleeves rolled up" support on all business development and deal-making activities, with a focus on life sciences and health informatics, including prospecting and sourcing potential partners and creating compelling pitch material. In addition, this position is expected to interface frequently with UB’s Technology Transfer Office to move existing and new revenue-generating intellectual property (IP) toward commercialization with existing companies, while providing general strategic and operations support to the office of Business and Entrepreneur Partnerships (BEP).
The ideal candidate will be reliable, motivated, efficient, outcome-driven, and thrive in a fast-paced environment. The BDA is comfortable with both academic and commercial partners, is capable of fostering and growing networks, and serves as a resource for creating, evaluating, positioning, and identifying partnering opportunities for commercially relevant translational research. The BDA has a general understanding of medical devices, diagnostics, health informatics and drug development processes and the challenges associated with developing the aforementioned. As result of the diversity of responsibilities and the broad range of duties, it is essential that the candidate has the ability to bring vision to reality through collaborations with a broad range of individuals, groups, and organizations.
The BDA reports to the Director, Business Development & Industry Engagement in BEP, which is part of the Office of Research and Economic Development, supports commercialization of UB technologies and connects industry with UB faculty for research and development support. BEP includes several programs and units with specific technology focus areas, such as the New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS), the New York State Center of Excellence in Materials Informatics (CMI) and the Buffalo Institute for Genomics & Data Analytics (BIG).